menu search

CNTB / Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced that Dr. Zheng Wei, Co-Founder & CEO, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022 at 4:20 pm ET. Read More
Posted: Feb 9 2022, 07:00
Author Name: GlobeNewsWire
Views: 102165

CNTB News  

Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?

By Zacks Investment Research
October 20, 2023

Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?

Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and Haemonetics (HAE) have performed compared to their sector so far this year. more_horizontal

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?

By Zacks Investment Research
September 15, 2023

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its more_horizontal

Connect Biopharma to Participate in Upcoming September Investor Conferences

By GlobeNewsWire
August 24, 2023

Connect Biopharma to Participate in Upcoming September Investor Conferences

SAN DIEGO and TAICANG, China, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “C more_horizontal

Connect Biopharma stock up more than 40% after trial data

By Market Watch
March 17, 2023

Connect Biopharma stock up more than 40% after trial data

Connect Biopharma Holdings Ltd. CNTB, -3.51% stock rose more than 40% in the extended session Friday after the company said that analysis of a trial i more_horizontal

Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California

By GlobeNewsWire
February 6, 2023

Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California

SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage bio more_horizontal

Connect Biopharma Stock Plunges As Ulcerative Colitis Candidate Flunks In Mid-Stage Study

By Benzinga
May 4, 2022

Connect Biopharma Stock Plunges As Ulcerative Colitis Candidate Flunks In Mid-Stage Study

Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced topline results at 12 weeks from its Phase 2 trial for CBP-307 (CBP-307CN002) for ulcer more_horizontal

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

By GlobeNewsWire
February 9, 2022

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Compa more_horizontal

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

By GlobeNewsWire
February 9, 2022

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

SAN DIEGO and TAICANG, China, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Compa more_horizontal


Search within

Pages Search Results: